Delayed intubation is associated with mortality in patients with severe COVID-19: A single-centre observational study in Switzerland.


Journal

Anaesthesia, critical care & pain medicine
ISSN: 2352-5568
Titre abrégé: Anaesth Crit Care Pain Med
Pays: France
ID NLM: 101652401

Informations de publication

Date de publication:
08 2022
Historique:
received: 12 01 2022
revised: 28 03 2022
accepted: 28 03 2022
pubmed: 30 4 2022
medline: 2 8 2022
entrez: 29 4 2022
Statut: ppublish

Résumé

Switzerland experienced two waves of COVID-19 in 2020, but with a different ICU admission and treatment management strategy. The timing of ICU admission and intubation remains a matter of debate in severe patients. The aim of our study was to describe the characteristics of ICU patients between two subsequent waves of COVID-19 who underwent a different management strategy and to assess whether the timing of intubation was associated with differences in mortality. We conducted a prospective observational study of all adult patients with acute respiratory failure due to COVID-19 who required intubation between the 9 Two hundred twenty-three patients were intubated during the study period; 124 during the first wave, and 99 during the second wave. Patients admitted to the ICU during the second wave had a higher SAPS II severity score (52.5 vs. 60; p = 0.01). The time from hospital admission to intubation was significantly longer during the second compared to the first wave (4 days [IQR, 1-7] vs. 2 days [IQR, 0-4]; p < 0.01). All-cause ICU mortality was significantly higher during the second wave (42% vs. 23%; p < 0.01). In a multivariate analysis, the delay between hospital admission and intubation was significantly associated with ICU mortality (OR 3.25 [95% CI, 1.38-7.67]; p < 0.05). In this observational study, delayed intubation was associated with increased mortality in patients with severe COVID-19. Further randomised controlled trials are needed.

Identifiants

pubmed: 35487412
pii: S2352-5568(22)00073-X
doi: 10.1016/j.accpm.2022.101092
pmc: PMC9040513
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

101092

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.

Auteurs

Christophe Le Terrier (C)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland. Electronic address: christophe.leterrier@hcuge.ch.

Noémie Suh (N)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Hannah Wozniak (H)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Filippo Boroli (F)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Amélie Giudicelli-Bailly (A)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Frédéric Sangla (F)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

David Legouis (D)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Karim Bendjelid (K)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Hervé Quintard (H)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Jérôme Pugin (J)

Division of Intensive Care, Geneva University Hospitals, 4 Rue Gabrielle Perret-Gentil, 1211 Geneva 14, Switzerland; University of Geneva Faculty of Medicine, 4 Rue Michel Servet, 1204 Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH